“…[67] In intracellular immunity, TRIM21 was strongly reported to modulate the stability and activity of IRFs positively or negatively via ubiquitination, reportedly including IRF3, IRF5, IRF7, and IRF8 (Figure 3). Thereby, TRIM21 indirectly influence the level of cytokines in IRFs driven way, contributing to regulation of genes such as type I IFN (IFN-𝛼, IFN-𝛽), type II IFN (IFN-𝛾), IL-6, IL12, IL-12p40, and then differentiation of immune cell, mostly containing lymphocytes, [47,[68][69][70] macrophage, [61,66,71,72] mononuclear cells, [60,73] and so on. As the historical marker of autoimmune diseases, recent studies suggested TRIM21 was overexpressed in patient with SLE and induced ubiquitination of IRF3, IRF5, and IRF7, therefore enhancing the synthesis of type I IFN.…”